Gallium-68-MLN 6907
Alternative Names: 68Ga-MLN-6907; Gallium-68-MLN-6907Latest Information Update: 28 May 2018
At a glance
- Originator Millennium
- Developer Takeda Oncology
- Class Antineoplastics; Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 May 2018 No recent reports of development identified for phase-I development in Colorectal-cancer(Diagnosis, Metastatic disease) in Mexico (IV)
- 28 May 2018 No recent reports of development identified for phase-I development in Colorectal-cancer(Diagnosis, Metastatic disease) in USA (IV)
- 26 May 2016 Phase-I development is ongoing in USA